Evaluating cost-effectiveness in the evolving treatment landscape for metastatic urothelial carcinoma.
Validation of new prognostic factors for relapse in patients with clinical stage I seminoma. Time to real-world progression (TTrwP) among patients (pts) with relapsed/refractory (R/R) testicular germ ...
Systemic therapies in renal cell carcinoma with brain metastases: A comparative meta-analysis of immunotherapy and tyrosine kinase inhibitors. PSMA-positive tumor vessels around renal cell carcinoma ...
Germline correlates of clinical outcomes in aggressive prostate cancer subtypes treated with radiation therapy. Targeting highly aggressive ductal prostate tumours with poly ADP ribose polymerase ...
Real-world U.S. county-level analysis of erectile dysfunction diagnosis following radiation therapy for localized prostate cancer: The impact of rectal spacer utilization. This is an ASCO Meeting ...
Therapeutic approaches and outcomes in patients aged 50+ with germ cell tumours. Survival outcomes by salvage chemotherapy received.
Renal cell carcinoma in kidney transplant recipients receiving immunosuppression: A 55-year retrospective single-center study.
Developing a deep learning algorithm for automated p53 immunohistochemistry digital image analysis in prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...
Mental health monitoring in clinical trials for FDA-approved genitourinary cancer treatments: A decade review. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...
Genomic alterations in intraductal prostate cancer: Insights from the Genomic Umbrella Neoadjuvant study (GUNS) in high-risk localized disease. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Integrating aggressive variant prostate cancer–associated tumor suppressor genes (AVPC-TSG) status to refine prognosis and predict androgen-receptor pathway inhibitors (ARPI) response in metastatic ...
ABCA1 and ABCG1 cholesterol transporters expression on metastatic renal cell carcinoma: Impact on immunotherapy outcomes (CHOMET study). The prognostic role of circulating tumor DNA (ctDNA) clearance ...